Dermal Fillers Market is projected to exhibit 7.5% CAGR from 2023 to 2033 | FMI

The use of dermal fillers is not restricted to facial skin procedures, it also includes various derma aesthetic procedure treatment. Moreover, an increase in the number of non-invasive aesthetic surgeries and an increasing number of aesthetic surgeons are expected to be important factors for surging the demand for dermal fillers.

According to the Plastic Surgery Statistics Report, in 2019, there were around 13,618,735 non-surgical procedures performed by plastic surgeons worldwide.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5699

Additionally, increasing awareness concerning the dermal fillers in emerging countries, the emergence of new products and d new indications are enabling growth. Besides this, the rising ageing population is one of the major factors that is rapidly fuelling the demand for dermal fillers. The rising demand for anti-ageing treatment to effectively  diminish the signs of ageing and facial treatment will keep the demand for dermal fillers high.

FMI has projected absorbable dermal fillers to remain most preferred. It is expected to account for over 99% of dermal fillers sold through 2031.

Competitive Landscape

Companies operating in the Dermal Fillers market are aiming at strategic collaborations and acquisitions with the leading pharmaceutical companies to address the requirements of an expanding patient pool. For instance, in Jan 2019, Suneva Medical signed collaborative agreements with Healeon Medical and Bimini Technologies intending to shape the future of the regenerative aesthetics sector and expand the sales of aesthetic products. The company has built the success of Bellafill, the flagship brand, which was the first regenerative product and the longest-lasting dermal filler in the leading dermal fillers market.

Some of the companies are focusing on innovations and USFDA approvals to increase sales of dermal fillers market worldwide. For instance, U.S. FDA approved Galderma’s first hyaluronic acid filler Restylane® Kysse, used for various applications including upper perioral rhytids (wrinkles around upper lips) correction or lip augmentation.

Other than these strategies, key players are focusing on acquisitions and expansion of their global footprint as they await approvals from international organizations For instance, in May 2020, Anika Therapeutics acquired Parcus Medical, and Arthrosurface, a provider of the joint surface and preservation solutions for an active patient to hold its leading position in the aesthetic market, in Jan 2020.

Some of the leading companies operating in the Dermal Fillers market are:

• Galderma Pharma S.A
• Sinclair Pharma plc
• Zimmer Biomet Holdings
• Allergan plc.
• Anika Therapeutics Inc.
• Merz Pharma GmbH & Co. KGaA
• Suneva Medical Inc.
• Teoxane Laboratories Inc.
• Prollenium Medical Technologies Inc.
• Laboratoires Vivacy SAS
• Fidia Pharma USA Inc.

The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis is available in the report.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-5699

Key Takeaways of Dermal Fillers Market Study

• The global dermal fillers market will continue expanding at a steady pace. FMI has projected the market to exhibit 2.8% Y-o-Y growth in 2021
• The U.S. is one of the key markets for dermal fillers, accounting for over 89% of North America market in 2021
• Demand for dermal fillers is expected to remain significantly high in the U.K. FMI has projected it to exhibit over 5% Y-o-Y growth in 2021
• Germany and France are other lucrative markets for dermal fillers in Europe
• Dermal fillers sales in Japan are expected to be considerably high. South Korea too will continue exhibiting rising demand for dermal fillers

“Achieving approvals from international organizations and product launches are among key strategies adopted by the market players. They are primarily focusing on catering to the demand for non-invasive cosmetic procedures among patients,” says the FMI Analyst

Who is Winning?

The regulatory approval for new products is one of the key factor responsible for enormous competition among market players globally. Some of the leading market players have been focusing on product launches. Besides this mergers & acquisitions and collaboration remain the key trends among market players intending to expand their footprint globally.

For instance, AbbVie Inc., acquired Allergan Aesthetics, the onset of the completion of its acquisition of Irish-domiciled pharmaceutical company in January 2020. Allergan Aesthetics would operate as a new global dedicated business with its research & development function including aesthetic products, botox Cosmetic, the Juvederm collection of dermal fillers, and Coolsculpting body contouring.

Also, Revance Therapeutics signed an exclusive U.S. distribution agreement in January 2020 with Teoxane SA for its innovative Resilient Hyaluronic Acid products like RHA2, RHA3, and RHA4. Hence this agreement would expand the Teoxane’s aesthetic products sales.

In Oct 2020, Sinclair Pharmaceuticals Ltds. signed a strategic distributorship agreement with Tamer Group KSA, intending to expand its aesthetic profile sales footprint in the Middle East and Africa with its exclusive distributor in Saudi Arabia.